Clinical Trials Browser

Phase 3 × OTHER × Ranibizumab × Clear all

NCT00680225 2017-04-12

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma

Phase 3 Completed

10 enrolled 4 charts

Uveal Melanoma